cCD79a and IgH VDJ/DJ rearrangements are considered to be relatively specific for B lymphoid precursors. We looked for both in cCD3 þ , CD7 þ , CD19-T-ALLs classified by TCR status into ab or cd/immature (IM) lineages, with individualization of HOX11L2 þ T-ALLs since they represent an intermediate ab/cd category. cCD79a was expressed at low levels in 47% of T-ALL and was most frequent in IMc T-ALLs. IgH rearrangements were common in cd/IM (45%) and HOX11L2 þ (35%) T-ALLs compared to HOX11L2-negative cases (3%; Po0.001). CD127 (IL7Ra) expression was also more common in the cd/IM lineage but its expression was virtually mutually exclusive of IgH rearrangement. Low-level cCD79a expression alone should therefore not be interpreted as evidence of B lineage affiliation in immature leukemias. cd/IM lineage T-ALLs potentially include two distinct categories: predominantly IgH þ , cCD79a þ , CD127-cases which retain cd and B lymphoid potential and IgHÀ, cCD79aÀ, CD127 þ cases with restricted T lineage potential.
Introduction
The lymphoid B cell receptor (BCR) complex includes a membrane-bound Ig and a transmembrane signal transducing heterodimer, CD79, the B-cell equivalent of CD3 (reviewed in LeBien 1 ). CD79 comprises two polypeptides; CD79a (Iga) and CD79b (Igb) . While CD79b appears to be expressed as a single isoform, CD79a is expressed from two alternatively spliced transcripts, with the smaller one representing an immature form, whose protein is predicted not to form disulfide-linked dimers with CD79b but to maintain the transmembrane and cytoplasmic portions, thus permitting immunological detection. 2 Cytoplasmic (c)CD79a is expressed prior to CD19 during B lymphoid 3 development and is expressed by virtually all B-cell precursor ALLs (BCP-ALL). 4, 5 It is considered to represent a B lineage restricted marker, 6 although weak cCD79a expression has been detected by immunohistochemistry or flow cytometry in 10-40% of a limited number of T-ALLs. [7] [8] [9] [10] Incomplete immunoglobulin (Ig) DJ rearrangements first occur in CD34 þ , CD19À, CD10 þ , cCD79a þ early B cells, whereas VDJ rearrangements commence in CD19 þ , pro-B cells, just prior to appearance of cytoplasmic Igm and pre-BCR expression. [11] [12] [13] Whether the earliest IgH DJ rearranged, CD79a þ precursors are B lymphoid restricted is not clear. CD127 (IL7Ra) interaction has been reported to be a nonredundant cytokine for murine B and T lymphopoiesis but its role in human B lymphoid development is controversial. 1, 14 An early CD34 þ , CD19À, CD10À, cCD79a þ , CD127 þ cord blood B progenitor has recently been shown to demonstrate IgH DJ rearrangement and macrophage, natural killer (NK), B and T lymphoid potential. 15 IgH DJ rearrangements have also been reported in normal immature murine, 16 but not human, 12 thymocytes and in 22% of pediatric T-ALLs, particularly in TCRgd þ cases. 17 We have recently described a TCR-based classification which allows separation of T-ALLs into ab-lineage (TCRab/cTCRb expressing and/or TCRb VDJ rearranged T-ALLs) and gd lineage/immature (gd/IM) leukemias (TCRgd expressing or absence of complete TCRb rearrangement). 18 IM T-ALLs can be divided into those which have undergone TCRd (IMd) or TCRg (IMg) rearrangement and IM0 T-ALLs, with all TCR genes in a germline configuration. IMd/g T-ALLs clearly include gd precursors, 19 but they potentially also include leukemias with wider lymphoid potential. We therefore collectively refer to TCRgd þ and IMd/g T-ALLs as belonging to a gd/IM lineage. HOX11L2 expression in T-ALL is associated with a maturation arrest intermediate to the ab and gd lineages 20 and, as such have been individualized in the present study.
In an attempt to further analyze lineage affiliation and to assess the diagnostic significance of CD79a, we compared cCD79a and CD127 expression with IgH DJ and VDJ rearrangement in T-ALLs defined by their ab vs gd/IM lineage and their HOX11L2 þ expression.
Materials and methods
Diagnostic peripheral blood or bone marrow samples from 149 T-ALLs were analyzed with informed consent. Their clinical, immunological and genotypic characteristics and RAG1 expression have been described. [18] [19] [20] Inclusion criteria for T-ALLs included availability of material for monocentrique cCD79a staining, c/surface CD3 þ and CD7 positivity and CD19 and myeloperoxidase (MPO) negativity. Controls included 35 AMLs and 17 BCP-ALLs, defined by EGIL and FAB criteria, and 2 neonatal thymi. IL7Ra staining was performed using the SB/14-PE anti-CD127 monoclonal antibody (Becton Dickinson, Biosciences). cCD79a (HM57-phycoerythrin, DAKO, Glostrup Denmark) was detected by direct labeling of permeabilized cells (Harla Sera-Lab, England), and quantitated as a Ratio of mean Fluorescence Intensity (RFI). 21 The mean cCD79a fluorescent intensity of the blast population, defined by CD45/SSC (rarely SSC/FSC) gating and exclusion of residual normal B lymphocytes by double staining with CD7 or cCD3, was divided by the mean fluorescent intensity of the isotype control. IgH VDJ rearrangements were detected by multiplex, multifluorescent PCR, as described. 22 IgH DJ rearrangements were analyzed by two multiplex PCR with DH1-6 or DH7 primers developed within the BIOMED-2 Concerted Action, 'PCR-based clonality studies for early diagnosis of lymphoproliferative disorders (PL96-3936).
23
CD79a and CD79b amplification were performed by RT-PCR. Briefly, 100 ng cDNA was amplified for 35 cycles (941C 30 s, 551C 30 s and 681C 1 min) in the presence of 0.2 mM of each primer, 2 mM MgCl 2 and 1 U Taq polymerase in a 20 ml final volume. Primers CD79a sense: TCAAACTAACCAACCCACTGGGAG, CD79a reverse: GTGAGCTGAGACACTGGAGC, CD79b sense: GTCGGG GACAGAGCGGTGAC, CD79b reverse: GCAGCTCC GAAGCA GTCACTG and were provided by C Schiff, Centre d'Immunologie Marseille-Luminy.
RAG1 quantification was performed by RQ-PCR and expressed relative to logarithmic dilutions of the HBP-ALL T-cell line after normalization by the ABL housekeeping gene. (Table 1) . Intermediate RFI levels were also more common in this category (5/18; 28% compared to 9/124; 7%, P ¼ 0.006).
In order to determine whether the CD79a protein detected in T-ALLs corresponded to the alternatively spliced, shorter, nonfunctional isoforms, we evaluated which form of CD79a transcripts predominated in T-cell lines, in order to avoid RT-PCR amplification of normal residual B lymphocytes in T-ALL samples. As shown in Figure 2 , both CD79a and CD79b were amplified from peripheral blood lymphocytes and B-cell lines, neither from the K562 erythroid/myeloid cell line, and only CD79a from thymus and T-cell lines. Full-length transcripts predominated in all T-cell lines, with no obvious difference in the proportion of shorter transcripts between T-and B-cell lines. It therefore appears that the CD79a expressed by T-ALLs is potentially functional.
IgH rearrangements correlates with cCD79a expression and is virtually restricted to a gd/IM phenotype IgH rearrangements were seen in 31/141 (22%) T-ALLs. DJ rearrangement was seen in 28 cases (one case was also IgH VDJ þ ), VDJ in four. As described, 17 there was a high frequency of 3 0 DH segment usage, since 10/31 rearranged alleles used IgH DJ were found in 28 T-ALLs, one of which also demonstrated VDJ rearrangement. VDJ were identified in three HOX11L2+ ab-lineage and one TCRgd T-ALL. IgH DJ were found in 14/50 (28%) CD127-T-ALLs compared to only 2/30 (7%) CD127+ cases (P ¼ 0.02). c Includes three HOX11L2+ TCRgd T-ALLs.
IgH DJ rearrangements within T-ALL V Asnafi et al DH7, in keeping with primitive rearrangements. IgH rearrangement was virtually restricted to the gd/IM cases (22/49; 45%) and HOX11L2 þ cases (7/20; 35%) and was extremely rare in all other ab-lineage cases (2/64; 3%, Po0.001). As with cCD79a, IgH rearrangement was most common in IMg T-ALLs. It was more common in cCD79a þ compared to cCD79aÀ cases, both within the overall population (20/63, 31% vs 10/70, 14%, respectively; P ¼ 0.02) and within the gd/IM subgroup (15/25, 60% vs 6/23, 25%; P ¼ 0.02). It is noteworthy that no Ig rearrangements were detected in the ab-lineage T-ALL with high level CD79a expression (RFI 39). These data demonstrate that IgH rearrangement is virtually restricted to the gd/IM and HOX11L2 þ subgroups of T-ALLs and correlates with cCD79a expression.
IgH DJ rearrangement occur in low-level RAG1 expression within gd/ IM T-ALLs
As shown in Figure 3 , all four IgH VDJ rearranged T-ALLs demonstrated high-level RAG1 expression, as did 6/7 HOX11L2 and both ab-lineage cases with DJ rearrangement. In contrast, IgH DJ rearrangement in gd/IM cases occurred in the presence of much lower RAG1 levels, when IgH VDJ rearrangement was not seen. We have previously shown that partial TCRd and early TCRg rearrangements occur in the presence of relatively low-level RAG1 expression, whereas TCRd Jd1, mature TCRg and complete TCRb VDJ are only found in T-ALLs with levels above 1,E-02. 18 The present data are in keeping with a requirement for higher RAG1 levels for IgH VDJ compared to DJ rearrangement.
IL7Ra/CD127 expression define two subgroups of T-ALLs
Since IL7 plays an early role in lymphoid lineage specification, we looked for CD127 expression in 84 T-ALLs. Totally, 32 (38%) were positive (Table 1 ). Once again the highest incidence was seen in the gd/IM lineage, in keeping with the fact that IL7 is important for gd development.
14 CD127 expression was rare in HOX11L2 þ ab-lineage T-ALLs. Strikingly, IgH rearrangements and CD127 expression were mutually exclusive, particularly within the gd/IM lineage, when Ig rearrangements were seen in 11/17 (65%) CD127 negative compared to only 2/15 (13%) CD127 positive cases; P ¼ 0.003. This is in keeping with IL7-mediated orientation towards a T/NK/dendritic-macrophage precursor, as recently described, 15 rather than towards the B-cell lineage. Among gd/IM T-ALLs, only 2/14 cCD79a þ /IgH D-J þ cases were CD127 þ compared to seven of the 11 cCD79aÀ/IgH D-J-cases (P ¼ 0.02).
These data would suggest that IMd/g T-ALLs include two distinct categories: predominantly Ig þ , cCD79a þ , 
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Discussion
Flow cytometric analysis confirmed immunohistochemical evidence of cCD79a expression in approximately 50% of T-ALLs, demonstrating that low-level positivity in acute leukemia should not be taken to indicate a B lineage restricted nature. Expressing results as RFI allows distinction of BCP-ALL with high-level expression and T lineage cases with low-level expression, with little overlap. Our data indicate that semiquantification of cCD79a expression is preferable to histological assessment, when expression levels are difficult to evaluate. cCD79a is one of the most discriminating markers within the EGIL classification of acute leukemia, 6 with a value of 2 for B lineage affiliation. We suggest that such a value should be restricted to cases with high level (RFI45-10) cCD79a expression. The significance of low-level cCD79a expression in T-ALLs is not clear. Both cCD79a expression and IgH DJ rearrangement precede CD19 expression in pro-B cells, 3, 11, 12 but the demonstration that a CD34 þ , CD19À, CD10À, CD79a þ , CD127 þ , IgH DJ rearranged cord blood B progenitor has macrophage, NK, B and T lymphoid potential 15 suggested that it is not yet B lymphoid restricted. We show that both CD79a expression and, particularly, IgH DJ rearrangement are preferentially associated with TCRgd expressing T-ALLs and their precursors, IMd/g T-ALLs. It is possible that cross-lineage IgH rearrangements in T-ALL reflect transformation of a CD34 þ /CD19À precursor, which has initiated IgH DJ rearrangement and retains B and gd rather than ab-lineage potential. We believe that IgH DJ rearrangements and cCD79a expression in IMd/g T-ALLs are not simply a reflection of immaturity, since if this were the case, the incidence would be at least as high in IMd as IMg and potentially even higher in IM0 T-ALL, which was not the case. These data are suggestive of a continuous spectrum of lymphoid cells, with the gd-lineage being intermediate between the ab and B lymphoid lineages.
An alternative explanation could be aberrant postoncogenic events resulting from ongoing RAG activity within transformed precursors. We have shown that RAG1 activity was 10-100-fold higher within ab-lineage T-ALLs than IM and the majority of TCRgd T-ALLs. 18 Virtual absence of IgH rearrangements in ablineage T-ALLs is against postoncogenic events due to ongoing RAG-mediated recombinase activity. The fact that the majority of IgH DJ þ T-ALLs demonstrated low-level RAG1 transcripts suggests either that a prior wave of RAG1 expression led to their rearrangement or that, as for initial TCRd and TCRg rearrangements, 18 low-level RAG1 expression suffices for IgH DJ (but not VDJ) rearrangement. This does not explain the virtual absence of IgH DJ rearrangement in ab-lineage precursor T-ALLs, suggesting that IgH locus accessibility differs in ab and gd lineage precursors.
Approximately one-third of T-ALLs expressed CD127, the IL7Ra. As for IgH DJ rearrangement and CD79a expression, the highest incidence of expression was found in the gd-lineage cases. This is in keeping with the known role of IL7 in TCRgd development. 24 More strikingly, it was possible to divide IMd/g T-ALLs into predominantly Ig þ , cCD79a þ , CD127À cases and IgÀ, cCD79aÀ,CD127 þ cases. IL7 has been shown to be an indispensable cytokine for both B and T murine lymphopoiesis.
14 Its role in human T gd and, to a lesser extent, ab lymphopoiesis is also established but its role in human B lymphopoiesis is less clear. Several lines of evidence suggest important differences between murine and human B lymphopoiesis. Severe combined immuno-deficiency patients with IL7Ra mutations lack T lymphopoiesis but demonstrate normal B-cell development 25 and human B-cell development in vitro does not require IL7. 26 We have recently demonstrated that T-ALLs reproduce, at least in part, normal thymic populations. 18 The identification of independent IgH þ , cCD79a þ , CD127À and IgÀ, cCD79aÀ, CD127 þ T-ALLs within the IMd/g category suggests that IL7Ra expression within an immature CD7 þ , cCD3 þ CD4/8 double-negative precursor identifies early T-cell lineage commitment whereas its absence, particularly in the presence of CD79a expression and/or IgH DJ rearrangement indentifies a precursor with B and gd lineage potential. Whether the former population demonstrates ab-lineage rather than gdlineage potential is not clear. The data presented here will allow selection of normal thymic precursors in which the preferential development potential suggested above can be tested.
We have shown that HOX11L2 þ T-ALLs are associated with an intermediate stage of maturation arrest between the ab and gd lineages. 20 These T-ALLs frequently demonstrate IgH DJ rearrangement but differ from gd-lineage, IgH DJ þ T-ALLs by their relatively high RAG1 levels and by less-frequent CD127 expression. Both may be explained by relative maturity, since the majority of HOX11L2 þ T-ALLs are arrested at the IMb, pre-ab or pTa þ /TCRgd þ stages. It is noteworthy that IgH DJ rearrangements were not seen in HOX11 þ T-ALLs (data not shown), which demonstrate IMb and pre-ab but not TCRgd þ stages of maturation arrest. Given the high level of homology between HOX11 and HOX11L2, comparison of the consequences of their expression on Ig/TCR locus accessibility is likely to improve our understanding of normal and pathological lymphoid development.
